Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

Editor's Note - This issue of MedicinMan is dedicated to the memory of Dr. Tarun Gupta, TG as he was fondly called. Executive Editor, Salil Kallianpur, dear friend Subrato Banerjee and long-time MedicinMan patron Vivek Hattangadi, pen their tributes to TG.

Articles by Anup Soans, K. Hariram, Cambridge Consultants, Sunil Bajaj and Phanish Chandra

Q 1. Tell us about your journey as a pharma entrepreneur and what made you venture into pharma and stay on in pharma? My journey started with two good decisions, one- to be a Medical Representative (MR) in Mumbai, which built a strong foundation and the other, to join Helios, a new pharma company, which was like a baptism of fire. Together, they molded me well. I was promoted as a Front Line Manager (FLM) within a year. And after spending four excellent years in Helios, I joined Group Pharma as Product Manager (PM) and ever since, it’s been an exciting learning experience.  I was exposed to Pharma very early in life as my dad was in J L Morison, as part of the promoter-team of Warren Pharma. At home, I was the designated telephone operator and order processing clerk. Those were the days of trunk-calls - calling managers and distributors to note down orders. Hence, I was exposed to the excitement of targets, achievements, deficits and campaigns very early in my life. The idea of ‘work-life balance’ was not in vogue. One would look to their parents who worked long hours with pride making it something you wanted to emulate. Things have changed a lot but I would not trade the decision I made, to get into and stay in Pharma.

As professionals, we are conditioned to be "fixers." We...

🚀 The Mega-Merger That Wasn't Early August saw the...

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Beyond the Pharmacy of the World: Why India's Biopharma...

Something remarkable has happened in the Indian pharmaceutical market....

🚀 The Mega-Merger That Wasn't Early August saw the...

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Beyond the Pharmacy of the World: Why India's Biopharma...

Something remarkable has happened in the Indian pharmaceutical market....

🚀 The Mega-Merger That Wasn't Early August saw the...

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Beyond the Pharmacy of the World: Why India's Biopharma...

Something remarkable has happened in the Indian pharmaceutical market....

🚀 The Mega-Merger That Wasn't Early August saw the...

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Beyond the Pharmacy of the World: Why India's Biopharma...

Something remarkable has happened in the Indian pharmaceutical market....